Ramky Infrastructure FY26 profit rises, declares dividend
Ramky Infrastructure Limited reported a 40% increase in consolidated net profit to ₹2,827.75 million for FY26, driven by an exceptional gain from the sale of a stake in Visakha Pharmacy Limited, despite a decline in revenue. The board approved a 10% final dividend and the incorporation of a new subsidiary in the UAE, while the statutory auditors issued an unmodified opinion highlighting significant write-offs and write-backs.

*this image is generated using AI for illustrative purposes only.
Ramky Infrastructure Limited reported a consolidated net profit of ₹2,827.75 million for the financial year ended March 31, 2026, an increase from ₹2,017.46 million in the previous year. The board, meeting on May 27, 2026, approved the audited financial results for both standalone and consolidated operations. The company's revenue from operations for the year stood at ₹18,464.78 million, compared to ₹20,445.38 million in the prior year. The board approved the payment of a final dividend of 10% on the nominal value of the equity share of ₹10 each for FY25-26, subject to shareholder approval.
Financial Performance
The company posted a profit before tax of ₹3,540.76 million for FY26, up from ₹3,310.87 million in the prior year. Basic earnings per share (EPS) for the year increased to ₹39.17 from ₹27.28 in FY25. For the quarter ended March 31, 2026, the company reported a net profit of ₹521.15 million, reversing from a net loss of ₹120.45 million in the same quarter of the previous year. On a quarterly basis, revenue came in at approximately ₹5 billion, compared to ₹4.9 billion in the same quarter of the prior year.
The table below summarises the full-year consolidated financial performance:
| Metric: | FY26 (₹ in Million) | FY25 (₹ in Million) |
|---|---|---|
| Total Income | 20,415.40 | 22,104.48 |
| Total Expenses | 17,469.22 | 18,793.60 |
| Net Profit | 2,827.75 | 2,017.46 |
| Basic EPS | 39.17 | 27.28 |
Board Decisions
The board approved the resignation of Mr. Kesava Datta N as Company Secretary and Compliance Officer, effective June 30, 2026. The directors also approved the incorporation of a subsidiary in the United Arab Emirates to enter the water and wastewater sector and other infrastructure works.
Auditor's Report and Key Notes
Statutory auditors M/s. Suryanarayana Reddy & Co. issued an audit report with an unmodified opinion. The auditors drew attention to the write-off of receivables amounting to ₹723.48 million and the write-back of liabilities totaling ₹68.40 million during the quarter and year ended March 31, 2026. An exceptional item of ₹594.60 million was recorded in the consolidated results, relating to the gain on the sale of a 51% equity stake in subsidiary Visakha Pharmacy Limited.
Historical Stock Returns for Ramky Infrastructure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.35% | -7.31% | -13.14% | -29.89% | -25.94% | +166.09% |
What is the strategic rationale behind Ramky Infrastructure's decision to expand into the water and wastewater sector in the UAE?
How will the sale of the 51% stake in Visakha Pharmacy Limited impact the company's long-term revenue diversification strategy?
What are the expected capital requirements and timeline for establishing the new UAE subsidiary?































